Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 14, 2014; 20(22): 6968-6973
Published online Jun 14, 2014. doi: 10.3748/wjg.v20.i22.6968
Published online Jun 14, 2014. doi: 10.3748/wjg.v20.i22.6968
Total number of patients | 36 |
Age, yr (mean) | 65 (37-83) |
Gender, male/female | 30/6 |
Etiology, HBV/HCV/non-BC | 9/23/4 |
Chronic hepatitis/liver cirrhosis | 3/33 |
Child-Pugh score, A/B/C | 8/19/3 |
Hepatocellular carcinoma, stage I/II/IIIa/IVb | 1/2/29/4 |
Grade of portal vein invasion, VP0-2/VP3/VP4 | 19/11/6 |
Previous treatment for Hepatocellular carcinoma, Y/N | 26/10 |
Location of bile duct obstruction, intrahepatic/extrahepatic | 13/23 |
Location of bile duct stricture, unilobular/bilobular | 11/25 |
Hemobilia, present/absent | 12/24 |
Following treatment for hepatocellular carcinoma, Y/N | 15/21 |
- Citation: Sugiyama G, Okabe Y, Ishida Y, Saitou F, Kawahara R, Ishikawa H, Horiuchi H, Kinoshita H, Tsuruta O, Sata M. Evaluation of endoscopic biliary stenting for obstructive jaundice caused by hepatocellular carcinoma. World J Gastroenterol 2014; 20(22): 6968-6973
- URL: https://www.wjgnet.com/1007-9327/full/v20/i22/6968.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i22.6968